Success Metrics

Clinical Success Rate

66.7%

Based on 2 completed trials

Completion Rate

67%(2/3)

Active Trials

0(0%)

Results Posted

100%(2 trials)

Terminated

1(17%)

Phase Distribution

Ph not_applicable

83%

Ph phase_1

17%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 1Safety & dosage

1(16.7%)

N/ANon-phased studies

5(83.3%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(2)

Terminated(1)

Other(2)

Detailed Status

Completed2

unknown2

Terminated1

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

Phase 1

Trials by Phase

Phase 11 (16.7%)

N/A5 (83.3%)

Trials by Status

terminated117%

completed233%

unknown233%

not_yet_recruiting117%

Recent Activity

0 active trials

Showing 5 of 6

not_yet_recruitingnot_applicable

Investigating Modulation of Neuropathic Pain by Transcranial Magnetic Stimulation: a Multimodal Imaging and Electrophysiological Approach

NCT07758348

completednot_applicable

Clinical Trials (6)

Showing 6 of 6 trials

NCT07758348Not Applicable

Investigating Modulation of Neuropathic Pain by Transcranial Magnetic Stimulation: a Multimodal Imaging and Electrophysiological Approach

Not Yet Recruiting

NCT03628703Not Applicable

Response Inhibition in Tourette Syndrome

Completed

NCT03259568Not Applicable

Effects of rTMS on Human Brain Activity Measured With fMRI

Terminated

NCT03817385Not Applicable

rTMS and Robotic Gait Training in Patients With Stroke

Unknown

NCT03273439Not Applicable

A Study of rTMS for Cognitive Deficits in Chronic Patients With Schizophrenia

Completed

NCT01918787Phase 1

rTMS for Adults With Autistic Spectrum Disorder

Unknown

All 6 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 6